Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about MKKGY

Recent news which mentions MKKGY

WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?

February 16, 2025

Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics

February 11, 2025

GSK To Buy US-Based Stomach Cancer Drug Developer For Over $1 Billion

January 13, 2025

Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition

December 12, 2023

Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis

December 06, 2023

Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors

September 26, 2023

Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023

August 03, 2023

Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List

July 26, 2023

Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation

June 20, 2023

Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions

April 18, 2023

FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study

April 12, 2023

Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer

March 27, 2023

Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval

March 23, 2023

With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics

January 20, 2023

PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment

January 03, 2023

Mersana Inks Cancer Therapy Development Deal With Merck Germany

December 23, 2022

SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19

October 19, 2022

Germany's Merck Slapped With Formal French Investigation Related To Its Thyroid Drug

October 19, 2022

PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers

October 11, 2022

Here's How Day One Biopharmaceuticals Stock Could Keep Climbing

June 15, 2022

Germany's Merck To Launch Semiconductor Base In China

May 31, 2022

Wall Street Thinks Palantir Is Poised for a Comeback. Here's Why

April 22, 2022

Cathie Wood Can't Get Enough of These 2 Biotech Stocks

March 31, 2022

TSM Looks To Hire Over 8,000 People In 2022

January 24, 2022

Despite Palantir’s Impressive Deals, Its Losses and Valuation Make It Unappetizing

January 21, 2022

The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings

November 18, 2021

GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact

September 30, 2021

Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study

September 21, 2021

Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial

August 24, 2021

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.